Class II — Potential Health Hazard

Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.

T12. Incorporates wireless electrocardiographic technology to achieve the real-time acquisition Recalled by WELCH ALLYN, INC/MORTARA Due to Impacted Welch Allyn products may not meet the...

Date: March 18, 2020
Company: WELCH ALLYN, INC/MORTARA
Status: Terminated
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact WELCH ALLYN, INC/MORTARA directly.

Affected Products

T12. Incorporates wireless electrocardiographic technology to achieve the real-time acquisition and RF transmission of simultaneous 12-lead ECG data with diagnostic quality while allowing the patient to be ambulatory.

Quantity: 78,521 units total

Why Was This Recalled?

Impacted Welch Allyn products may not meet the Defibrillation Withstand requirements of EN/IEC 60601-2-25 Medical Electrical Equipment.

Where Was This Sold?

This product was distributed nationwide across all 50 states.

Affected (51 states)Not affected

About WELCH ALLYN, INC/MORTARA

WELCH ALLYN, INC/MORTARA has 11 total recalls tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report